![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Simvastatin, With butylated hydroxyanisole, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2008-149 - Rev 02
This Chemical Type CEP, issued on March 18, 2021, remains in force until May 03, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 1563 associated with this CEP further emphasizes